Comprehensive quantification of purine and pyrimidine metabolism in Alzheimer's disease postmortem cerebrospinal fluid by LC-MS/MS with metal-free column.
A metabolome presence of nucleobases, nucleosides, nucleotides and related phosphorylated metabolites has been examined for the pathological Alzheimer's disease (AD). Although reversed-phase liquid chromatography tandem mass spectrometry (LC-MS/MS) enabling the determination of these analytes has been used, they were limited in chromatographic signal intensity and reproducibility due to significant peak tailing caused by complexing with metallic cations and phosphate groups. In this work, we applied the LC-MS/MS with metal-free column for comprehensive quantification of 40 analytes regarding to purine and pyrimidine metabolism in postmortem cerebrospinal fluid (pCSF) from AD. For the analytical column, an InertSustain AQ-C18 metal-free PEEK column was used. MS detection is electrospray positive ionization. Metal-free column allows for a sharp peak detection of highly polar metabolites within running time (17 min). In validation, LOD, LOQ and recovery using pooled pCSF sample showed 1-500 nM, 0.5-250 nM and a range of 53.1%-144.0% (RSD ranged from 0.4% to 19.6%). The developed LC-MS/MS method utilizing a metal-free column provides an accurate quantification of some metabolites regarding to purine and pyrimidine metabolism in pCSF sample obtained from AD patient.